| INCYTE DL-,001 |
| USA |
| Gesundheit |
| US45337C1027 / 896133 |
| ICY (Frankfurt) / INCY (NASDAQ) |
| FRA:ICY, ETR:ICY, ICY:GR, NASDAQ:INCY |
| S&P500 |
| https://incyte.com/ |
|
Incyte Corporation is a biopharmaceutical company that focuses on the discovery, development, and commercialization of proprietary therapeutics for serious medical conditions. The company concentrates on hematology and oncology, as well as inflammati..
>Volltext.. |
| 22218.73 Mio. EUR |
| 18284.98 Mio. EUR |
| 4984.44 Mio. EUR |
| 1659.93 Mio. EUR |
| 1381.01 Mio. EUR |
| 6.96 EUR |
| 32.78 Mio. EUR |
| 3410.91 Mio. EUR |
| 1695.62 Mio. EUR |
| 3.46 |
| 30.92% |
| 90.97% |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 10.172.587 Euro. |
| INCYTE |
| 26.08.26 |
|